Home › Funds › FULLER & THALER ASSET MANAGEMENT, INC. › JAZZ

FULLER & THALER ASSET MANAGEMENT, INC. position in JAZZ

JAZZ PHARMACEUTICALS PLC · Health Care

FULLER & THALER ASSET MANAGEMENT, INC. reported holding 1,398,444 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$323.8M, representing 0.95% of its reported portfolio and ranking #11 among its reported holdings. FULLER & THALER ASSET MANAGEMENT, INC. has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)1.40M sh
Reported value held$323.77M
Portfolio Weight0.95%
First reportedQ1 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How FULLER & THALER ASSET MANAGEMENT, INC.'s JAZZ position evolved

FULLER & THALER ASSET MANAGEMENT, INC. first disclosed a stake in JAZZ in Q1 2024 at 1,085,140 shares (US$130.7M). The position peaked in Q2 2026 at 1,638,544 shares, worth US$394.8M. Across 11 filings, FULLER & THALER ASSET MANAGEMENT, INC. increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,398,444 shares valued at US$323.8M — a reduction of -240,100 shares quarter over quarter.. Notable position changes include a 57% trim in Q2 2024 (shares rose 4% over the following quarter), a 117% increase in Q4 2024 (shares were roughly flat over the following quarter), a 42% increase in Q1 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.09M $130.67M New
Q2 2024 469.67K $50.13M Reduce
Q3 2024 432.12K $48.14M Reduce
Q4 2024 939.35K $115.68M Add
Q1 2025 1.33M $165.24M Add
Q2 2025 1.63M $172.87M Add
Q3 2025 1.63M $214.32M Hold
Q4 2025 1.68M $285.11M Add
Q1 2026 1.68M $316.87M Hold
Q2 2026 1.64M $394.84M Reduce
Q3 2026 1.40M $323.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 40 other funds we track also report a position in JAZZ — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M), Boston Trust Walden Corp (US$98.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has FULLER & THALER ASSET MANAGEMENT, INC. held JAZZ?

FULLER & THALER ASSET MANAGEMENT, INC. has disclosed JAZZ holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is FULLER & THALER ASSET MANAGEMENT, INC.'s current position in JAZZ?

As of Q3 2026, FULLER & THALER ASSET MANAGEMENT, INC. holds 1.40M shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $323.77M, representing 0.95% of its reported portfolio and ranking #11.

Has FULLER & THALER ASSET MANAGEMENT, INC. been buying or selling JAZZ?

In the latest 13F filing (Q3 2026), FULLER & THALER ASSET MANAGEMENT, INC. reduced its position in JAZZ. The position peaked in Q2 2026 at 1.64M shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, Boston Trust Walden Corp, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.